UK fertile ground for switching
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescriptionto- OTC reclassification. David Ridley explores the country’s increasingly attractive switch environment.